Banque Cantonale Vaudoise Sells 1,329 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Banque Cantonale Vaudoise cut its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 28.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,264 shares of the construction company’s stock after selling 1,329 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Aspen Aerogels were worth $78,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of ASPN. NorthCrest Asset Manangement LLC purchased a new stake in shares of Aspen Aerogels in the second quarter worth $217,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Aspen Aerogels by 38.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after acquiring an additional 3,607 shares in the last quarter. Calamos Advisors LLC purchased a new position in shares of Aspen Aerogels during the second quarter worth about $328,000. Virtu Financial LLC bought a new position in shares of Aspen Aerogels in the first quarter worth approximately $246,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Aspen Aerogels by 10.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock worth $341,000 after purchasing an additional 1,339 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Price Performance

Shares of Aspen Aerogels stock opened at $26.31 on Wednesday. The stock has a market capitalization of $2.00 billion, a P/E ratio of -59.80 and a beta of 2.15. Aspen Aerogels, Inc. has a one year low of $5.94 and a one year high of $33.15. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The business’s 50 day simple moving average is $24.71 and its two-hundred day simple moving average is $22.50.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The company had revenue of $117.80 million during the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm’s revenue was up 144.4% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.22) EPS. Analysts forecast that Aspen Aerogels, Inc. will post 0.21 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on ASPN shares. Benchmark reissued a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a research note on Thursday, August 8th. Barclays initiated coverage on shares of Aspen Aerogels in a research report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 target price for the company. Piper Sandler raised their price target on Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, May 29th. TD Cowen upped their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Finally, Craig Hallum raised their price objective on Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a report on Friday, June 14th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $29.70.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 4.30% of the stock is currently owned by company insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.